Contrast ICE for Myocardial Scar in VT Ablations

• Status: Completed
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

There is a high correlation between scar areas identified by contrast-enhanced ICE and scar areas identified by conventional electroanatomic mapping. Therefore, the investigators will assess the utility of contrast-enhanced ICE to identify and localize myocardial scar real-time during VT ablation procedures.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Weill Medical College of Cornell University
• Collaborator: Biosense Webster, Inc.

Criteria

Inclusion Criteria:

• Subject is 18 years of age or older

• Subject is undergoing catheter ablation of likely reentrant VT

• Planned use of intracardiac echocardiography (ICE)

• Subject is willing to sign and date the study informed consent form

Exclusion Criteria:

• Contraindication to Perflutren (Optison) echo contrast

• Known right-to-left, bidirectional, or transient right-to-left cardiac shunts

• Known hypersensitivity to Perflutren, blood, blood products or albumin

• Subject has medical condition that would limit study participation (as per MD discretion)

• Subject is pregnant

• Inability to give informed consent